Exosomes in Alzheimer's Disease: Potential Role as Pathological Mediators, Biomarkers and Therapeutic Targets
- PMID: 32840760
- DOI: 10.1007/s11064-020-03111-1
Exosomes in Alzheimer's Disease: Potential Role as Pathological Mediators, Biomarkers and Therapeutic Targets
Abstract
The concept of exosomes has been progressively changed from the status of cellular trashcans to multitasking organelles involved in many processes, including internalization, transport and transfer of macromolecules such as proteins, lipids and nucleic acids. While underpinning the mechanisms behind neurodegeneration and neuronal loss, exosomes were shown to be involved in carrying pathological misfolded proteins, propagation of β-amyloid protein and hyper-phosphorylated tau proteins across the brain that ultimately leads to the onset of Alzheimer's disease (AD), the most prevailing multifactorial neurodegenerative disorder. A potential novel therapeutic role of exosomes in AD intervention is suggested by their ability to increase Aβ clearance. This review aims to highlight the important pathological mechanisms as well as therapeutic strategies involving exosomes towards AD prevention.
Keywords: Alzheimer´s disease; Biomarkers; Exosomes; Tau protein; β-amyloid.
References
-
- Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M (2016) World Alzheimer report 2016- improving healthcare for people living with Dementia. Coverage, quality and costs now and in the future.
-
- Querfurth HW, LaFerla FM (2010) Alzheimer’s disease. N Engl J Med 362:329–344 - PubMed
-
- Hampel H, Prvulovic D, Teipel S, Jessen F, Luckhaus C et al (2011) The future of Alzheimer’s disease: the next 10 years. Prog Neurobiol 95:718–728 - PubMed
-
- Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science 297:353–356 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical